Why it matters. Publishers and advertisers lose both ad delivery and the tracking scripts used to measure campaign performance as native browser blocking spreads beyond extensions.
Signal from The Measure · Mike Gasbara · read the original.
What’s happening, why it matters, who reported it, who followed, and how the story develops. Free with a reader account. Unsubscribe any time.
Continue free →Adweek’s Kendra Barnett reports that prescription drug brands can now advertise within Google’s AI Overviews and AI Mode, per an exclusive from colleague Trishla Ostwal. The move extends paid placement into Google’s generative-AI search surfaces for a previously restricted ad category.
Help.openai.com documents that OpenAI matches conversion events to ad clicks using a click reference called oppref, advanced matching, and modeled measurement when direct signals are incomplete, deduplicating pixel and API events via a shared event ID.
OpenAI’s help center details Ads Manager Beta policy, listing categories like telehealth, prescription drugs, and payday loans as fully barred. Credit cards, mortgages, and crypto are restricted to a small group of pre-approved advertisers only.